Back to Directory
Origin-1
by Absci
AI Application
Low Confidence
Origin-1 is a generative AI platform for the de novo design of therapeutic antibodies targeting 'zero-prior' epitopes—sites with no previously known structural data or existing treatments
Transparency Score
Weighted across four pillars · updated May 18, 2026
Overall grade
29% weighted
Model
—
Not yet assessed
Infrastructure
—
Not yet assessed
Capabilities
Text Generation
Summarization
Translation
Conversation
Code Generation
Vendor Information
Complete information about the vendor/provider of this AI application
AbsciView all products →
Absci
Contact Information
Registered Address
18105 SE Mill Plain Blvd, Vancouver, Washington (WA), 98683, United States
EU AI Act Provider Information
Verification Status:
Partially Verified
Absci
18105 SE Mill Plain Blvd, Vancouver, Washington (WA), 98683, United States
Compliance Documents
CE Marking: Not Applicable
Compliance & Risk
Get insights into risk by running assessments on this AI application.
Work at Absci? Claim this listing to correct or complete the data.
Added: May 18, 2026
Updated: May 18, 2026
Ready to manage AI applications?
Track, assess, and govern your AI applications with Anove.